Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinjiang An

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Experimental and Therapeutic Medicine|June 2, 2017
Myocardial fibrosis in congenital and pediatric heart diseaseJing Tian, Xinjiang An, Ling Niu
Experimental and Therapeutic Medicine|December 5, 2017
Cardiovascular risks in chronic kidney disease pediatric patientsJing Tian, Ling Niu, Xinjiang An
Experimental and Therapeutic Medicine|January 27, 2017
Role of microRNAs in cardiac development and diseaseJing Tian, Xinjiang An, Ling Niu
Experimental and Therapeutic Medicine|June 8, 2017
Correlation between NF-κB signal pathway-mediated caspase-4 activation and Kawasaki diseaseJing Tian, Xinjiang An, Ling Niu
Minerva Pediatrica|September 23, 2016
Pediatric cardiovascular risk factorsJing Tian, Xinjiang An, Mingyu Fu
Minerva Pediatrica|September 23, 2016
Rehabilitation during congenital heart disease in pediatric patientsJing Tian, Xinjiang An, Ling Niu
Experimental and Therapeutic Medicine|January 20, 2017
Promising effects of Chinese traditional treatment for child typhoid complicated by myocarditisJing Tian, Xinjiang An, Mingyu Fu, et al.
Experimental and Therapeutic Medicine|October 5, 2016
Emergency treatment and nursing of children with severe pneumonia complicated by heart failure and respiratory failure: 10 case reportsWanli Li, Xinjiang An, Mingyu Fu, et al.
Experimental and Therapeutic Medicine|April 14, 2016
Role of the PTEN/PI3K/VEGF pathway in the development of Kawasaki diseaseXinjiang An, Haitao Lv, Jing Tian, et al.
Experimental and Therapeutic Medicine|September 8, 2016
Significance of serum 25-hydroxyvitamin D<sub>3</sub> and interleukin-6 levels in immunoglobulin treatment of Kawasaki disease in childrenXinjiang An, Mingyu Fu, Jing Tian, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Experimental and Therapeutic Medicine|June 2, 2017
Myocardial fibrosis in congenital and pediatric heart diseaseJing Tian, Xinjiang An, Ling Niu
Experimental and Therapeutic Medicine|December 5, 2017
Cardiovascular risks in chronic kidney disease pediatric patientsJing Tian, Ling Niu, Xinjiang An
Experimental and Therapeutic Medicine|January 27, 2017
Role of microRNAs in cardiac development and diseaseJing Tian, Xinjiang An, Ling Niu
Experimental and Therapeutic Medicine|June 8, 2017
Correlation between NF-κB signal pathway-mediated caspase-4 activation and Kawasaki diseaseJing Tian, Xinjiang An, Ling Niu
Minerva Pediatrica|September 23, 2016
Pediatric cardiovascular risk factorsJing Tian, Xinjiang An, Mingyu Fu
Minerva Pediatrica|September 23, 2016
Rehabilitation during congenital heart disease in pediatric patientsJing Tian, Xinjiang An, Ling Niu
Experimental and Therapeutic Medicine|January 20, 2017
Promising effects of Chinese traditional treatment for child typhoid complicated by myocarditisJing Tian, Xinjiang An, Mingyu Fu, et al.
Experimental and Therapeutic Medicine|October 5, 2016
Emergency treatment and nursing of children with severe pneumonia complicated by heart failure and respiratory failure: 10 case reportsWanli Li, Xinjiang An, Mingyu Fu, et al.
Experimental and Therapeutic Medicine|April 14, 2016
Role of the PTEN/PI3K/VEGF pathway in the development of Kawasaki diseaseXinjiang An, Haitao Lv, Jing Tian, et al.
Experimental and Therapeutic Medicine|September 8, 2016
Significance of serum 25-hydroxyvitamin D<sub>3</sub> and interleukin-6 levels in immunoglobulin treatment of Kawasaki disease in childrenXinjiang An, Mingyu Fu, Jing Tian, et al.
Pageof 3